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Expression of intercellular adhesion molecule-1 
(ICAM-1) by keratinocytes is an important event in 
the pathogenesis of T -cell-mediated inflammatory 
skin diseases . To determine if ICAM-1 expression 
could be selectively modulated, two antisense phos-
phorothioate oligonucleotides (S-ODN) targeting the 
translation initiation and 3' untranslated regions of 
ICAM-1 mRNA were added as lipid complexes to 
cultures of keratinocytes. Interferon-/, was added 
after 24 h to induce ICAM-1 expression, which was 
quantitated by flow cytometry after 48 h. The S-ODN 
targeting the translation initiation site did not inhibit 
ICAM-1 expression at 0.2-20.0 /tM. In contrast, 0.2-
1.0 /tM of the S-ODN targeting a site in the 3' 
untranslated region abrogated ICAM-1 expression in 
up to 75% of the keratinocytes; this inhibition was 
reversible when cOinplementary sense S-ODN was 
added. Phosphodiester ODN (PD-ODN) targeting the 
A ntisense technology has gained increasing experi-mental and clinical interest as a tool to selectively modulate expression of particular gene products [1-5] . Antisense o ligodeo" .. ynucleotides (ODN) have been demonstrated to block ill vitro translation 
of mRNAs in a sequence-specific manner. DNA o ligomers present 
distinct advantages over RNA oligomers in that they are more 
stable in cell-free systems and in cultured cells [1,6] . Because the 
utility of ODN with the conventional phosphodiester backbone 
structure is limited due to their high susceptibility to degradation by 
nucleases, modined ODN such as phosphorothioates (S-ODN) 
have been developed and successfully employed [7-8]. Some 
striking examples for the ill /litro effects excrted by S-ODN are the 
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same sites did not inhibit ICAM-1 expression on 
keratinocytes, most likely as a consequence of rapid 
degradation. Inhibition of ICAM-1 by the antisense 
S-ODN was selective; expression of /32-microglobu-
lin, a3-integrin, and IH-integrin remained largely 
unaffected and interferon--y-induced HLA-DR ex-
pression was inhibited to a much lesser extent than 
ICAM-t. Antisense-non-specific inhibition was also 
noted in that two scrambled S-ODN with an identical 
nucleotide (14 of 20 cytosines) composition inhibited 
ICAM-1 expression in up to 44% of the keratinocytes, 
whereas a degenerate S-ODN did not. The data dem-
onstrate the complex effects exerted by antisense 
S-ODN in that ICAM- 1 expression was inhibited via 
antisense-non-specific mechanisms probably due to 
the intrinsic properties of the S-ODN as well as via 
the anticipated sequence-specific mechanisms. 
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inhibition of HIV replication [9], oncogene expression [10,11] and 
modulation of cytokines and growth factors [10,12-14]. 
The aim of this study was to dctermine if interferon-y (IFN-y)-
induced intercellular adhesion mol ecule-1 (rCAM-l) expression on 
cultured human kerati.nocytes could be inhibited by phosphorothio-
ate ODN (S-ODN). ICAM-1 is upregulated on keratinocytes in 
various inflammatory skin disorders and is thought to be a critical 
f.1ctor in lymphocyte trafficking [15]. Inhibition oflCAM-l expres-
sion on keratinocytes may be bcneficial in the treatment of T 
cell-mediated inflammatory skin diseases. We tested two antisense 
S-ODN; one targeting the translation-initiation site and the other a 
stem-loop structure at the 3' -untranslated region of ICAM-l 
mRNA that have been previously identifi ed as inhibitors of cyto-
kine-induced ICAM-l expression [1 6]. We have also characterized 
parameters that are critical for antisense-indu ced ICAM-1 inhibi-
tion in kcratinocytes, such as the presence of liposomes and the 
backbone nature of the antisense ODN. 
MATER.lALS AND METHODS 
Rcagcnts Lipofectin was purchased from Gibco BRL (Ga.ithersburg. 
MD) and used at 10 p.g/ ml in all experiments . Recombinant human IFN-y 
was obtained from Boehringer Mannheim (Inglewood, NJ) . Fluorescein 
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Sequence (5' .. 3 ') 
CCC CCA CCA CTT CCC CTC TC 
CCC CCA CCA crr CCC CTC TC 
CCT CAC CCC CCT ACC TCT CC 
CCT CAC CCC CCT ACC TCT CC 
TCC ACC CTC CAC TCC CTC CC 
GAG AGG GGA AGT GGT GGG GG 
TGG GAG CCA TAG CGA GGC 
GCA TAG GGC GAA CGG TGC 
21-mer 
isothiocyanate (FITC)-conjugated F(ab'), fragments of goat anti-mouse 
IgG were obtained from Tago, Burlingame, CA. Mouse IgG2a and a 
monoclonal antibody (MoAb) to HLA-DR (mouse IgG2a) were purchased 
from Becton Dickinson (San Jose, CA), MoAb (mouse IgG2a) to ICAM-1 
(CD 54) and /32-microglobulin from ·Monosan (Uden, Netherlands). MoAb 
from mouse ascites against /31- and a3-integrin were purchased from 
Chemicon (Temecula, CA). 
Oligonucleotide Synthesis Phosphorothioate (S-OD N) and phos-
phocliester (PD-OON) oligodeoxynucleotides complementary to two re-
gions of the human ICAM-1 mRNA that had been previously identified as 
sensitive targets for antisense-induced inhibition [16] were synthesized by 
cyanoethyl phosphoramidite chemistry on an Applied Biosystems Model 
380B DNA synthesizer. Sulfurizing reagent (Glen Research, Sterling, VA) 
was used according to the manufacturers' instructions. ODN were ethanol-
precipitated in the presence of sodium acetate, washed in 70% ethanol, and 
resuspended in sterile water. Aliquots of each sample were analyzed for 
purity by acrylamide denaturing electrophoresis. The concentration of the 
synthesized ODN was detern1ined by their optical density at 260 nm. The 
characteristics and sequences of the ODN employed are listed in Table I . 
Additionally, phosphorothioate trinucleotides (G-G-G, G-A-G, T-G-G, 
G-T-G, G-T-G, G-G-A) complementary to nucleo tide sequences shared by 
AS1, SCR1a, and SCtUb were also synthesized. InternaUy fluorescinated 
S-OON (FITC-ODN) were synthesized using fluorescein-on phosphora-
midite (Clontech, Palo Alto, CA) following manufacturer's instructions . 
Human Keratinocytes Normal human epidermal keratinocytes were 
purchased from Clone tics (San Oiego, CA) and grown in a modified 
se rum-free keratinocyte growth medium (Gibco). All keratinocytes were 
utili zed in experiments at the fourth to sixth passages. Cell s were cultured 
in a humiclified incubator at 5% CO 2 and 37°C . 
Oligonucleotide Treatment of Keratinocytes 1.06 keratinocytes 
were cultured in 25-ml culture flasks (Falcon, Oxnard, CA) overnight to 
aUow adherence. The next day, culture media were removed and ce lls were 
incubated in medium (2 ml) containing lipid-ODN complexes at 37°C for 
4 h. Lipid-ODN complexes were formed by incubating 10 ILg/mllipofectin 
with different concentrations ofODN added as 100 X stock solutions for 15 
min at room temperature prior to addition to cells. After the 4-h incubation 
period, flasks were twice washed with 5 ml Ca + + - and Mg ++ -free 
phosphate-buffered saline (PBS) (Biofluids, Rockville, MD) and fresh 
medium supplemented with S-ODN, but without lipofectin, was added. 
Cells were incubated for an additional 24 h at 37°C and then stimulated 
with 1000 U/ml recombinant human IFN-1' (Boehringer) for an additiona l 
24 h (previously determined to be optimal for inducing 1CAM-1 expres-
sion) . 
Figure 1. Lipofectin does not significa.ntly inhibit 
lFN-y-induced upregulation of keratinocyte 
mlgG2a 
Specificity 
3' -untranslated region (ISIS 1939 in [16]) 
3'-untranslated region (ISIS 1939 in [16]) 
Scrambled to AS1 
Scrambled to PD-AS1 
Scrambled to AS1. 
Sense strand to AS1 
AUG translation initiation codon (ISIS 1570 in [16]) 












Phenotypic Analysis of Cells by Flow Cytometry Keratinocytes 
were removed from tissue-culture flasks by incubation at 37°C in a 0.25% 
trypsin/ethylenediaminetetraacetic acid solution (Gibco) for 2-4 min. For 
flow-cytometry studies, cells were washed twice in PBS supplemented with 
5% feta l bovine serum and 0.02% NaN" the buffer used in all subsequent 
washes. 106 cells were incubated with 15 ILl of unconjugated specific or 
control antibody (mouse IgG2a) at 10-15 ILg/ml at 4°C for 30 min . After 
three washes, cells were incubated with 15 ILl of a fluoresceinated goat 
anti-mouse antibody (1: 1 000). Samples of 104 viable cells were then 
analyzed hy flow cytometry on a FACScan II (Becton Dickinson) using the 
consort 30 software program. Dead cells were excluded by gating out cell s 
containing propiclium ioclide (50 ILg/ml in PBS). 
Immunofluorescence Microscopy Keratinocytes (106 ) were seeded in 
chamber slides (Nunc, Naperville, IL) 24 h prior to the standard antisense 
treatment (as described above). After treatment with fluoresceinated (FITC) 
antisense ODN for 24 h, the chambers were removed and the slides were 
washed three times in PBS. Slides were air-dried "lld were mounted 
immediately prior to fluorescence microscopy to prevent elution of FlTC-
ODN from the cells. 
RESULTS 
Effect of Lipofectin on IFN-y-Induced Upregulation of 
Keratinocyte Surface Molecules Keratinocytes do not consti-
tutively express ICAM-l and HLA-DR on their surface [17]. For 
this reason, keratinocytes were incubated (24 h) with 1000 U/ml of 
IFN- 'Y, a known inducer of these surface molecules [17]. Because 
preliminary experiments showed that ICAM-l ASl and AS2 did 
not affect ICAM- l expression on keratinocytes at concentrations of 
up to 5 IJ.M (data not shown), we attempted to increase the cellu lar 
uptake of the ODN as a complex with the cationic lipid lipofectin, 
as previously reported [16,18]. In preliminary experiments, the 
effect of different concentrations of lipofectin (0.1-20.0 IJ.g/ml) on 
the cellular metabolism ofkeratillocytes was studied using the MTT 
[3, (4,5-dimethylthiazol-2-yl)-2,5- diphenyl tetrazoUum bromide] 
assay. A concentration of 10 IJ.g/ml lipofectin, added to cultures of 
keratinocytes for 4 h, was chosen because it was the highest 
concentration that had no significant inhibitory effect on keratino-
cyte metaboUsm, as determined by the MTT assay (data not 
shown). Induction of ICAM-l, HLA-DR, and (32-microglobulin 
on keratinocytes was not significantly affected by incubation with 
A r\.-mlgG2a B ,-mlgG2• C 
ICAM-l, lILA-DR, or /32-microglobulin expression. 
Untreated or IFN-y-treated keratinocytes were trypsinized 
prior to staining with mIgG 2• or MoAb against HLA-DR., 
ICAM-1, or /32-microglobulin (A-C). Keratinocytes do not 
constitutively express ICAM-l and HLA-DR but do express 
significant amounts of /32-microglobulin (A). ICAM- 1 and 
HLA-DR expression arc significantly upregulated 24 h after 
stimulation with 1000 U/ml of IFN-1' (B) . This IFN-I'-
induced induction of ICAM-I and HLA-DR and the con-
stitutive expression of /32-microglobu lin is not significantly 
inhibited when keratinocytes are cultured in media supple-
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Figure 2. The lipofectin-dependent nuclear distribution of 
ICAM-l ASl (S-ODN) is critical for the inhibition of IFN-y-
induced ICAM-l expression. Keratinocytes were treated with 0.5 /-I.M of 
AS1 as a S-ODN (A-D) or PD-ODN (E-F) in terna lly labeled with 
fluorescein (PITC). ASl was either applied in the absence (A ,C,E) or 
presence (B,D,F) of 10 /-I.g/ mllipofectin. Cultures C-D were air-dr.ied 24 h 
after treatment with ASl (S-ODN) with (C) and without (D) lipofectin and 
mounted for flu orescence microscopy (Scale bars, 20 /-I.m). Keratinocytes 
were also treated with P1TC-labeled AS l as a PD-ODN in the absence (E) 
or presence (F) of li pofectin . Cul tures A-B and E-F were treated with 
IPN-'Y after 24 h and trypsinized after 48 h. Cell suspensions were examined 
for fluorescence in tens ity either immediately or after incubation with a 
phycoerythrin (PE)-Iabeled MoAb against ICAM-l. Keratinocytes treated 
with P1TC-ASl as a S-ODN without lipofectin show a significant uptake of 
the antisense that has no e£fect on IFN--y-induced expression of ICAM-1 
(A). As shown in C, ASl (S-ODN) accumulate in the cytoplasm. In 
contrast, ASl (S-ODN) is taken up to a larger extent in the presence of 
lipofectin accompanied by a significant (> 60%) inhibi tion of IFN--y-
induced ICAM-l expression (B). Under these conditions, P1TC-ASl is 
pr.imarily localized throughout the cell (D). W hen FITC-ASl is applied as 
a PD-ODN in the presence (E) or absence (F) ofl0 /-I.g/m1lipofectiJ], there 
is OItly marginal green fluorescence with no alteration of ICAM- t expres-
sion (E). 
lipofectin when compared to control cultures not receiving lipo-
fectin (Fig 1) . 
Lipofectin-Mediated Nuclear Uptake of ICAM-l Antisense 
S-ODN Correlates with Biologic Activity Keratinocytes 
treated with a fluorescinated (FITC) phosphorothioate (S-ODN) 
ICAM-1 antisense (AS1) in the absence of Iipofectin accumulated 
FITC-AS1 (Fig 2A), which showed a cytoplasmic distribution (Fig 
2Q. Cytoplasmic uptake of ASl S-ODN did not alter IFN-y-
induced ICAM-l ex 'Pression (Fig 2A). In contrast, treatment of 
keratinocytes with FITC-ASl (S-ODN) plus Iipofectin resulted in 
an increased cellular uptake (Fig 2B) with prominent localization in 
the nucleus (Fig 2D) and a significant decrease in the staining 
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intensity for ICAM- l (Fig 2B). FITC-labeled PD-ASl did not 
accumulate in cells in the absence (Fig 2E) or presence (Fig 2F) of 
lip 0 fectin. 
Differential Inhibition of IFN--y-Induced ICAM-l Expres-
sion on Keratinocytes by S-ODN ASI and AS2 The ability of 
most keratinocytes to express ICAM-l after IFN-y treatment was 
inhibited by ASl (which targets a site in the 3' -w~translated region 
of the ICAM-l mRNA) when keratinocytes were used at the fourth 
to sixth passages. Inhibition ofICAM-l expression 011 up to 70% of 
keratinocytes was achieved at a concentration of 0.5 J.LM (Fig 3B). 
Two scrambled S-ODN (SCRla and SCRlb) with a nucleotide 
composition identical to that of AS1 also significantly inhibited 
ICAM-l expression on keratinocytes but to a lesser extent (Fig 
3C-D) . However, no inhibition ofICAM-l expression was seen in 
the presence of a degenerate 21-mer antisense (DEG AS) that had 
a random nucleotide composition at each position (Fig 3E). When 
a phospho diester analog of AS1, PD-AS1, was used in the presence 
oflipofectin at 0.5 to 100 J.LM, neither IFN-y-induced ICAM-l nor 
HLA-DR expression on keratinocytes were affected (data not 
shown) . Fluorescence-activated cell sorter (FACS) analysis of 
keratinocytes treated with a FITC-Iabeled analog of PD-ASl 
revealed that only minute amounts ofPD-AS1 could be detected in 
keratinocytes (Fig 2E,F). Immunofluorescence microscopy of ke-
ratinocytes treated with FITC-PD-ASl did not reveal significant 
intracellular fluorescence (data not shown). AS2, the S-ODN that 
targets the AUG initiation codon of the ICAM-l mRNA, had no 
inhibitory effect on either IFN-y-induced ICAM-l or HLA-DR 
ex.'Pression at concentrations of 0.2 to 20.0 J.LM (data not shown). 
Specificity of Inhibition of ICAM-l AS1 To detemune 
whether ASl specifically targeted ICAM-l expression, the effect of 
AS1 on HLA-DR, {32- microglobulin, and a3- and {31-integrin 
expression was also studied (Fig 4) . IFN-y-induced HLA-DR 
expression on keratinocytes was significantly, although not com-
pletely reduced with ASl (Fig 4A) . Similar inhibition ofHLA-DR 
e"'Pression was seen in the presence of the controls SCRla and 
SCRlb (Fig 4B-Q, but not by the DEG AS (data not shown). 
Because HLA-DR is expressed only at moderate levels 24 h after 
treatment with IFN-y, the effect of the S-ODN on IFN-y-induced 
HLA-DR expression was also studied after 48 h. Even though 
HLA-DR was upregulated to a greater extent at this time, it was 
significantly inhibited by ASl and the scrambled controls SCRla 
and SCRl b (data not shown). To determine whether tlus inhibition 
was restricted to IFN-y-induced molecules, other surface mole-
cu les were studied. {32-microglobulin is constitutively expressed on 
keratinocytes but is also upregulated to some extent upon treatment 
with IFN-y (Fig 1). Neither ASl nor the scrambled controls 
SCRla and SCR1b significantly inhibited {32-microglobu1in ex-
pression on keratinocytes (Fig 4D-F). In addition, constitutive 
expression of a3- and {31-integrins was not affected by AS1 or 
SCRla (Fig 4G-J). 
Inhibition of ICAM-l Expression by ASI Is Prevented by 
Preincubation with the Cotnpletnentary Phosphorothioate 
Sense Strand To determine whether the observed inhibition of 
ICAM-l and HLA-DR by ICAM-1 AS1 could be prevented, AS1 
was preincubated with the complementary sense strand SSl iden-
tical to the tal'geted mRNA region prior to treatment of keratino-
cytes (Fig 5). The sense str311d SSl alone at 0.2-1.0 J.LM had no 
inhibitory effect on IFN-y-induced ICAM-l or HLA-DR expres-
sion on keratinocytes (data not shown). Preincubation of AS1 with 
equal concentrations of SSl abrogated antisense-dependent inhibi-
tion of ICAM-l 3l1d HLA-DR ex 'Pression. In contrast, preincuba-
tion of ASl with the degenerate 21-111er (DEG AS) had no 
significant effect on ICAM-1 and HLA-DR inhibition (Fig 5). 
Preincubation of SCR1a and SCRlb witl~ SSl partially prevented 
their inhibition of ICAM-l and HLA-DR expression whereas 
preincubation with the DEG AS did not (data not shown). 
Inhibition ofIFN--y-induced ICAM-l Expression by ASI Is 
Prevented by Preincubation with the Phosphorothioate 
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IFN-y A IFNy+AS1 B 
Figure 3. ICAM-l ASl inhibits ICAM-l expression 
on keratinocytes. Keratinocytes were treated with AS1, 
SCRla, SCRlb, and DEG AS in the presence ofl0 JLg/ml 
lipofectin for 4 h and were stimulated with 1000 &/ml 
lPN-'Y for an additional 24 h . Cell suspensions were then 
reacted with a MoAb against ICAM-l. Greater than 85% of 
the keratinocytes arc ICAM-l + after treatment with IPN-'Y 
(A) as compared to 0 -5% in untreated keratinocytes (gates 
are set on untreated keratinocytes reacted with a MoAb 
against ICAM-l). AS1 at 0.5 JLM inhibits ICAM-l on 
60.5% of all keratinocytes (B) . Two scrambled controls for 
AS1 with identical nucleotide compositions, SCRla (C) 
and SCRlb (D), also significantly inhibit ICAM-l expres-
sion at a concentration of 0.5 JLM , though to a lesser extent. 
No inhibition of ICAM-l expression is seen in the presence 
ofa degenerate 21-mer S-OD N, DEG AS, at 0.5 JLM (E). 
IFNy+SCR1 a C IFNy+SCR1 b D IFNy+DEG AS E 
Trinucleotide G-G-G Because AS1 displays significant homo-
logy with SCR1 a and SCR1 b due to the high content of cytosines 
(Table I), we wanted to further study the relevance of shared 
nucleotidc sequences in the inhibition of IPN--y-induced ICAM-1 
and HLA-DR expression. Phosphorothioate trinucleotides com ple-
c 
jl2-MICROGLOBULIN 
0 mlgG" E ,..."lgG •• F 
mlgG2.I 
lFN-y )FN"'"! /FN"'"! 
;ry:FI/y+AS1 !,\IFI/y+SCR10 !,\IFI/y+SCR1b 
UU "- 1/ .k, . \ U L' " ~., 
Figure 4. ICAM-l ASl partially inhibits expression ofHLA-OR but 
not of 1l2-microglobulin. 1l1-integrin. and a3-integrin. Keratino-
cytes were treated with AS1, SCRl a, or SCRl bat 0.5 JLM plus lipofectin 
for 4 h prior to stimulation with IPN-'Y for an additional 24 h. Cells were 
then trypsinized and some cell suspensions wcre reacted with mlgG;" or 
MoAb against HLA-DR (A-C) , /32-microglobulin (D-F) , /31-integrin 
(G-H), or mlgG, plus MoAb against a3-integri.n (l-J) . lPN-y-induccd 
HLA-DR exprcssion on keratinocytes is significantly inhibited by ASl (A), 
SCRla (B), and SCRlb (C). Expression of /32-microglobulin is not 
inhibited by AS1 (D), SCR.l a (E), and SCRlb (F) . Constitutive expression 
of /31-integrin is not altered by ASl (G) or SCRla (H). a3-integrin 
expression is also not affected by AS) (1) or SCRla (f). 
rtJ.entary to common nucleotide repeats in AS1, SCRla, and 
SCR1b were preincubated with AS1 and SCRla to test their abi lity 
to block S-ODN-dependent inhibition of the IFN-y-induced 
e,o::pression oflCAM- l and HLA-DR. These S-ODN were G-G-G 
G-A-G, T-G-G, G-T-G, and G-G-A. Preincubation of 0.5 fLM Asi 
with G-G-G at 5 fLM completely prevcnted AS1-dependent inhi-
bi-tion of IFN-y-induced ICAM-1 expression (Fig 6) as weB as 
aLA-DR expression (data not shown). Prt;!incubation of SCRla 
with G-G-G abrogated inhibition of IFN-y-indllced ICAM-l or 
aLA-DR expression by SCRla in an analogous manner (data not 
s.-,.own). Cocultllre of keratiJlocytes with G-G-G ,at 5 fLM alone did 
not alter IFN-)l-indllced expression of ICAM-l or HLA-DR. In 
contrast, preincubation of AS1 at 0.5 fLM with either S-ODN 
y-G-G, G-T-G, G-G-A, or G-A-G (Fig 6) at 5 /-LM did not affect 
i.,.hibition of IFN-y-indllced ICAM-l or HLA-DR expression by 
AS1. In one experiment, S-ODN of different length (3- to 21-mer) 
consisting only of cytosines neither inhibited IFN-y-iJlduced 
ICAM-lnor HLA-DR expression at 5 fLM (3-mer) or 0.5 fLM (6-, 
9/. 15-, 2l-mer) (data not shown). 
DISCUSSION 
VUe have studied the effects of two ICAM-l phosphorothioate 
oVgodeoxynucleotides (S-ODN) on IFN--y-iJlduced expression of 
A HLA-DR B 
/,S1 
: ..... /SlIDEG AS 
:. I . TAL 
S1/SS 
F~gure 5. Sequence-specific inhibition of IFN--y-induced ICAM-l 
01" HLA-OR expression by AS! is blocked by dte complementary 
s~nse strand. Keratinocytes were treated with ASl alone, AS1 plus SS, or 
i\.Sl plus DEG AS (all at 0.5 p.M) prior to stimulation with IFN-'Y. Cell 
s,jspensions were then stained with a MoAb against ICAM-l (A) or 
J-iLA-DR (B). Most keratinocytes express ICAM-l (A) upon treatment 
with IPN-'Y (CTRL, --). Incubation ofkeratinocytcs with ASl at 0.5 p.M 
ppor to stimulation with lPN-'Y signjficantly inhibits ICA M-l expression 
( ... ). When ASl is preincubated with equal concentrations of SS, anti-
s~nse-depcndent inhibition of ICAM-l is completely abrogated ( ... .. ) . 
Pl"eincubation of AS1 with DEG AS does not block inhibition of ICA M-l 
e7"pression (- - -). HLA-DR expression (B) is similarly induced by IFN-'Y 
after 48 h on most keratinocytcs (CTRL, --). Incubation ofkeratinocytes 
with ASl at 0.5 p.M prior to stimulation with IFN-'Y significantly inhibits 
14LA-DR expression ( ... ). When AS1 is preincubated with equal concen-
tcations of SS, antisense-dependent inhibition of HLA-DR is completely 
avrogated ( . .... ). Preincubation of ASl with DEG AS does not block 
il1-hibition of HLA-DR. expression (- - -). 
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FN-y+ AS1 + 
G-A-G 
Figure 6. Phospborothioate trinucleotides complementary to ~e­
peated nucleotide sequences in ASl bave differential effects on ~e 
inhibition of IFN-y-induced ICAM-l expression by AS!. Kerati~o_ 
cyt"s were treated with ASl at 0.5 J..LM alone or widl ASl at 0. 5 4M 
preincubated with the trinucleotides G-G-G or G-A-G (all at 5.0 J.LM) Pl:':ior 
to stimulation widl IFN-y. IFN-y-stimuIated keratinocytes and ceLIs treated 
as described above were then stained with a MoAb against rCAM-I. Most 
IFN-y-treated keratinocytes express ICAM-l (--). Treatment with 1\.Sl 
significantly inhibits IFN-y-induced ICAM-l expression ( . .. ). Preincuba_ 
tion of ASl with the S-ODN G-G-G completely blocks tlus inhibition. of 
rCAM-1 expression ( .... ). In contrast, preincubation of ASt with ·the 
S-ODN G-A-G does not prevent AS1-dependent inlubition of IFN"y .... 
induced ICAM-l expression ( ............ ). 
ICAM-1 on human keratinocytes . These two S-ODN, targeti.ng 
the AUG translation initiation codon (AS2) and a stem-loop 
structure at the 3'-untranslated region (AS1), have been previously 
identified as efficient inhibitors of cytokine (IFN-')I, interleukin'-l, 
tumor necrosis fuctor-a) .... induced ICAM-1 expression on endotl-:te_ 
lial cells and a lung carcinoma cell line [16). In contrast to th~se 
recently reported findings [16] , only AS1, targeting the 3'-untra.t:ts_ 
lated region of the ICAM-1 mRNA, proved to be active in 
inhibiting the IFN--y--induced upregulation of ICAM-1 expression 
on human keratinocytes. AS2 , targe ting the AUG initiation codon 
region did not inhibit ICAM-1 on keratinocytes even at tenf~ld 
higher concentrations than had been reported to be e fficient [1 «5). 
As demonstrated by Chiang ct ai, significant inhibition of IFN_ 
-y--induced ICAM-1 expression was only achieved when antisCl-:tse 
S-ODN were complexed to the cationic lipid lipofectin [16]. In Qur 
experiments, lipofectin at 10 J.l.g/ml significantly increased the 
uptake of antisense S- ODN (Fig 2). Perhaps more importantly, 
lipofectin altered the subcellular distribution of the S-ODN, as 
previously described [5 ,8]: lipofectin-dependent nuclear enrich_ 
m ent of AS1 (S-ODN) correlated directly with the inhibition of 
IFN--y--induced ICAM-1 expression by AS1 (Fig 2). Lipofectin 
alone did not significantly alter IFN--y--induced upregulation of 
ICAM-1 and HLA-DR expression and the cellular metabolism of 
keratinocytes (Fig 1) [16]. Our results strongly suggest a criti<;::al 
role for the nuclear localization of the S-ODN in antisel\se 
inhibition . However, these findings are in contrast to those of 
N estle et ai, who demonstrated a significant nuclear uptake of 
S-ODN by up to 38% keratinocytes in the absence of lipofect:in 
[19]. Their system differed from ours in that keratinocytes we,re 
treated with S-ODN at tenfold higher concentrations. No expla_ 
nation was given in their study why only a minority ofkeratinocytes 
showed tlus particular pattern of intracellular uptake . Howev~r, 
both studies demonstrated that there is a sigluficant increase in the 
intracellular uptake of S-ODN in the presence of lipofectin i n 
essentially all keratinocytes with a typical nuclear staining pattc:r:n 
that goes along with the biologic activity of the AS S-ODN. 
These studies also illustrate the importance of choosing appro_ 
priate controls to rule out non .... antisense-specific effects caused by 
the nucleotide composition of a particular antisense reagent. \l\T e 
designed two scrambled S-ODN controls with a nucleotide co!),,)_ 
position identical to ICAM-1 AS1. Both of these caused a signifj_ 
cant, although less pronounced (than AS1), inlubition of ICAM,-l 
expression (Fig 3) . SCR1a and SCR1b also inhibited HLA-DR 
expression to some extent. To control for effects of the phosph~_ 
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rotluoate backbone, a degenerate 21-m er S-ODN (DEG AS) was 
also used as a control and had no significant inlubitory effects on 
ICAM-l expression . We thus concluded that these scrambled 
control S-ODN displayed intrinsic phamlacologic effects depen-
dent on tlleir nucleotide composition (Table I). In tlus particular 
case, tile lugh content of cytosines in ASl did not allow a design of 
a scrambled ODN without partial homology to AS1, w luch may 
allow some degree of hybridization to the site of the ICAM-1 
mRNA complementary to ASl (Table I). T he observed inlubition 
of ICAM-l by ASl was sequen ce- specific and required single-
stranded ODN in that preincubation of ASl with a "sense strand" 
S-ODN identical to the targeted mRNA region (SS1) abolished the 
inlubitory effect of ASl on ICAM-1 expression (Fig 5) . 
Preincubation e:-.:p eriments with trinucleotides complementary to 
nucleotide sequences shared by AS1 and the control S-ODN 
SCR1a and SCR1b demonstrated that the cytosine repeats (C-
C-C) contributed to the observed inlubitioll of IFN--y--induced 
ICAM-l and HLA-DR expression by all S-ODN. The significance 
oftlus finding is , however, unknown. In the case of AS1, hybrid-
ization of the G-G-G S-ODN to the complementary cytosine triplet 
(5 X) in the antisense may prevent hybridization to the targeted 
(complementary) mRNA region. Alternatively, aptameric inlubi-
tion of ICAM-1 and HLA-DR expression, depending on dIe 
C-C-C triplet in AS1, SCRla, and SCrlb, could also be inlubited 
by the G-G-G sequence. Evidence for a non .... sequence specific 
inlubition of a gene product based on the nucleotide content of dIe 
antisense has been also presented by Yawsen ct al [7) . In that study, 
the expression of the NB-1 gene (which encodes for a calmodulin-
like protein) could be inhibited by an tisense ODN containing 
contiguous stretches of guanosine residues that were not comple-
mentary to regions in the NB-l mRNA. However, our findings 
with the cytosine-only S-ODN tllat showed n o irrhibitory proper-
ties would mitigate against tlus possibility . 
T he phosphorothioate backbone structure was cri tical for 
ICAM-1 ASl to be effective, as all identical ODN with a phos-
phodiester backbone h ad no significant inlubitory effect on 
ICAM-l expression at con centrations ranging from 0.5 to 100.0 
J.LM . Tlus lack of inlubition is most likely due to dIe intracellular 
degradation of the PD-ODN by nucleases. Evidence for this has 
been presented in that keratinocytes treated with FITC-Iabeled 
PD-AS1 show n'linimal uptake for PD-AS1 (as deternlined by 
FACS analysis and immunofluorescen ce microscopy) in contrast to 
the lughly nuclease-resistant S-ODN analog, w hich shows a five-
to ten fold lugher intracellular accumul ation (Fig 2). 
Because IFN--y--induced HLA-DR expression was inhibited by 
ASl to some extent, additional surface molecules, such as {32-
microglobulin, f31-integrin , and a3-integrin were srudied. f32-
microglobulin expression was not affected by AS1, which is con-
sistent with dIe findings of Chiang c/ al [16]. T he same observation 
was m ade for a3- and {31-integrins, wluch are constitutively 
expressed on keratinocytes. We considered the possibility that 
HLA-DR expression was inlubited non-specifically because it was 
on ly mi.lumal.1y upregulated after 24 h . T lus was not the case, 
however, because HLA-DR expression was also significantly in-
lubited 48 h after treatment ofkeratinocytes with IFN-')I. Sequence-
specific inlubition was unlike ly because the mRNA for HLA-DR 
contains no regions complem entary to AS1. However, the mRNAs 
for the different HLA-DR alle les contain guanosine repeats (G-
G-G) at a relatively lugh frequency, which m ay account for a partial 
hybridiza tion of the cytosin e-t'ich AS1, SCRla, and SCR1b. Tlus 
may explain why the scrambled S-ODN controls SCRla and 
SCR1b also inhibi ted HLA-DR expression . 
Inhibition of IFN--y--induced ICAM-l and HLA-DR expression 
by ASl tllrough an interaction widl an IFN--y--responsive regula-
tory gene region or protein seems rather unlikely because IFN--y--
induced upregulation of f32-microglobulin was not affected. Fur-
thermore, AS1 also inhibited T N F-a .... and IL-1{3--induced ICAM-1 
expression [16] . T he antisense non-specific inlubition of IFN--y--
induced HLA-DR expression by ICAM-1 AS1 in our study is in 
contrast to the findings of N estle c/ al [19]. In dleir study, an AS 
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S-ODN targeting a site in the 3' -untranslated region of the ICAM-l 
mRNA inhibited IFN-y-induced expression of ICAM-l but not of 
HLA-DR. The conditions of their study were different in that the 
ICAM- l AS S-ODN (with a different nucleotide composition) was 
used at 5 J-LM (instead of 0.5 J-LM in our study), lipofectin at 5 J-Lg/ml 
(instead ofl0 J-Lg/mJ), and IFN-y at 10 U / m] for 48 h (in stead ofl000 
U/m1 for 24 h in our study). T he lack of comparability of both 
experimental systems is reflected by their finding that, at 1000 U/ml of 
IFN-y (used in our study), there was no significant inhibition of 
IFN- y-induced ICAM-l expression with their AS S-ODN. 
In addition to antisense-specific effects, antisense-non-specific 
activities seem to be a common effect of some S-ODN. Bennett e/ 
01 found a significant inhibition of T N F-a-induced expression of 
vascular ceU adhesion molecule (V CAM) in human umbilical vein 
endothelial ceUs upon treatment with an tisense S-ODN s again st 
E-selection and ICAM-l, or even with a control S-ODN [20]. T he 
authors concluded that these E-se1ecrin and ICAM-l S-ODN acted 
selectively on the targeted adhesion molecule in that VCAM 
expression was not affected at lower concentrations of these 
S-ODN, although these con~entrations were stiU effective in 
inhibiting the targeted gene product [20]. T he same observation 
holds true for the HLA-DR inhibition by ASl in our studies. T here 
is virtuaUy no inhibition at very low concen trations (0.1 J-LM)-the 
same concentration that causes some inhibition of IFN-y- induced 
ICAM-l expression . 
In summary, this study shows the complex biologic effects exerted 
by antisense ODN in addition to their an tisense-specific effects on the 
targeted gene product. We have addressed some factors (use of lipids 
for the quantitative and qualitative delivery of ODN , backbone 
stnlcture, controls, etc.) that are critical for the use of antisense ODN 
in human keratinocytes. Only careful consideration of these factors 
will allow one to take advantage of the potential of antisense ODN as 
modulators of gene expression il"l vitro and ill vivo. 
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